Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Cleveland HeartLab, Inc., often referred to as CHL, is a leading player in the cardiovascular diagnostics industry, headquartered in the United States. Founded in 2011, the company has rapidly established itself as a pioneer in advanced heart health testing, focusing on innovative solutions that enhance patient care and outcomes.
With a strong operational presence across major regions in the US, Cleveland HeartLab offers a comprehensive range of services, including advanced lipid testing and inflammation assessments. Their unique approach combines cutting-edge technology with a commitment to personalised medicine, setting them apart in a competitive market.
Recognised for their contributions to cardiovascular health, Cleveland HeartLab has achieved significant milestones, including partnerships with healthcare providers and a growing portfolio of proprietary tests. Their dedication to improving heart health continues to position them as a trusted resource for clinicians and patients alike.
+12 vs industry average
Cleveland HeartLab, Inc.’s score of 48 is higher than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Business Services is among the least carbon-intensive industries
The Business Services industry has reduced its overall emissions by 25% since 2018
No reported emissions data is available for Cleveland HeartLab, Inc. yet.
Cleveland HeartLab, Inc., headquartered in the US, currently does not report specific carbon emissions data for the latest year, as indicated by the absence of emissions figures. The company is a current subsidiary of Quest Diagnostics Incorporated, which may influence its climate commitments and reporting practices.
As part of its corporate family, Cleveland HeartLab's climate initiatives and performance may be aligned with those of Quest Diagnostics. However, specific reduction targets or achievements have not been disclosed for Cleveland HeartLab. The absence of documented reduction initiatives or Science Based Targets (SBTi) suggests that the company may still be in the early stages of formalising its climate strategy.
Given the lack of specific emissions data and reduction commitments, Cleveland HeartLab's climate impact remains unclear. The company may benefit from adopting industry-standard climate practices and setting measurable targets to enhance its sustainability profile in the future.
No climate goals have been disclosed for Cleveland HeartLab, Inc. yet.
No scope 3 category breakdown has been disclosed yet.


No peer comparison is available for Cleveland HeartLab, Inc. yet.
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more